Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Avidity Biosciences (RNA) Return on Assets (2020 - 2025)

Avidity Biosciences (RNA) has disclosed Return on Assets for 6 consecutive years, with 0.32% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Return on Assets fell 10.0% year-over-year to 0.32%, compared with a TTM value of 0.32% through Jun 2025, down 10.0%, and an annual FY2025 reading of 0.39%, down 9.0% over the prior year.
  • Return on Assets was 0.32% for Q2 2025 at Avidity Biosciences, down from 0.24% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.19% in Q1 2021 and bottomed at 0.38% in Q3 2022.
  • Average Return on Assets over 5 years is 0.3%, with a median of 0.3% recorded in 2022.
  • The sharpest move saw Return on Assets dropped -16bps in 2021, then grew 10bps in 2024.
  • Year by year, Return on Assets stood at 0.28% in 2021, then fell by -18bps to 0.33% in 2022, then decreased by -8bps to 0.35% in 2023, then soared by 38bps to 0.22% in 2024, then plummeted by -47bps to 0.32% in 2025.
  • Business Quant data shows Return on Assets for RNA at 0.32% in Q2 2025, 0.24% in Q1 2025, and 0.22% in Q2 2024.